A detailed history of Simplex Trading, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Simplex Trading, LLC holds 5,445 shares of LLY stock, worth $4.32 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
5,445
Holding current value
$4.32 Million
% of portfolio
0.17%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$772.14 - $960.02 $4.2 Million - $5.23 Million
5,445 New
5,445 $4.82 Million
Q1 2024

Apr 25, 2024

BUY
$592.2 - $792.28 $21.4 Million - $28.6 Million
36,141 New
36,141 $28.1 Million
Q3 2022

Nov 04, 2022

BUY
$296.48 - $337.87 $518,247 - $590,596
1,748 New
1,748 $565,000
Q2 2022

Aug 03, 2022

SELL
$278.73 - $327.27 $1.21 Million - $1.42 Million
-4,324 Closed
0 $0
Q1 2022

May 02, 2022

BUY
$234.69 - $291.66 $1.01 Million - $1.26 Million
4,324 New
4,324 $1.24 Million
Q2 2021

Aug 12, 2021

SELL
$180.55 - $233.54 $515,831 - $667,223
-2,857 Closed
0 $0
Q1 2021

Apr 26, 2021

BUY
$164.32 - $212.72 $469,462 - $607,741
2,857 New
2,857 $533,000
Q4 2020

Feb 02, 2021

SELL
$130.46 - $172.63 $7.71 Million - $10.2 Million
-59,071 Closed
0 $0
Q3 2020

Oct 14, 2020

BUY
$146.22 - $169.13 $1.72 Million - $1.98 Million
11,733 Added 24.79%
59,071 $8.74 Million
Q2 2020

Jul 13, 2020

BUY
$136.42 - $164.18 $6.46 Million - $7.77 Million
47,338 New
47,338 $7.77 Million
Q4 2018

Jan 16, 2019

SELL
$105.9 - $118.64 $23,086 - $25,863
-218 Closed
0 $0
Q3 2018

Oct 23, 2018

BUY
$85.86 - $107.31 $18,717 - $23,393
218 New
218 $23,000
Q2 2018

Jul 30, 2018

SELL
$75.7 - $86.88 $36,714 - $42,136
-485 Closed
0 $0
Q1 2018

Apr 26, 2018

SELL
$74.21 - $87.6 $959,461 - $1.13 Million
-12,929 Reduced 96.38%
485 $37,000
Q4 2017

Jan 10, 2018

SELL
$81.94 - $87.89 $1.76 Million - $1.88 Million
-21,432 Reduced 61.5%
13,414 $1.13 Million
Q3 2017

Oct 25, 2017

BUY
$77.07 - $85.54 $2.69 Million - $2.98 Million
34,846
34,846 $2.98 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $755B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.